KIF18B and bladder transitional cell carcinoma: In contrast, in hepatocellular carcinoma, cervical cancer, and bladder urothelial carcinoma, the modulation of tumor cell viability by KIF18B is associated with the Wnt/β-catenin pathway (Wu et al., 2018; Zhang and Liu, 2023; Liu et al., 2022).